Sutro Biopharma (STRO) Change in Receivables (2017 - 2025)
Sutro Biopharma (STRO) posted Change in Receivables of $55000.0 for Q4 2025, up 101.35% sequentially from -$4.1 million in Q3 2025, and down 97.2% YoY from $2.0 million in Q4 2024.
Sutro Biopharma (STRO) Change in Receivables (2017 - 2025) Analysis & Trends
Sutro Biopharma has reported Change in Receivables for 9 years, with the latest figure at $55000.0 in Q4 2025.
- Quarterly Change in Receivables fell 97.2% year-over-year to $55000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.6 million (up 83.11% YoY) and the FY2025 annual result came in at -$4.6 million, up 83.11% from the prior year.
- Change in Receivables rose to $55000.0 in Q4 2025 per STRO's latest filing, from -$4.1 million in the prior quarter.
- Over five years, Change in Receivables peaked at $86.0 million in Q2 2022 and troughed at -$86.4 million in Q3 2022.
- A 5-year average of -$79550.0 and a median of $125000.0 in 2021 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2022 and 2024: Change in Receivables surged 4348.27% in 2022, then sank 19425.4% in 2024.
- Over 5 years, Change in Receivables stood at $124000.0 in 2021, then slumped by 3429.03% to -$4.1 million in 2022, then jumped by 571.2% to $19.5 million in 2023, then slumped by 89.92% to $2.0 million in 2024, then plunged by 97.2% to $55000.0 in 2025.
- According to Business Quant data, Change in Receivables over the past three periods registered $55000.0, -$4.1 million, and -$5.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Sutro Biopharma | 339.58 Mn | 175.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55,000.00 |
| Dec 31, 2025 | 55,000.00 |
| Sep 30, 2025 | -4.08 Mn |
| Sep 30, 2025 | -4.08 Mn |
| Jun 30, 2025 | -5.56 Mn |
| Jun 30, 2025 | -5.56 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Sep 30, 2024 | -295,000.00 |
| Sep 30, 2024 | -295,000.00 |
| Jun 30, 2024 | -24.35 Mn |
| Jun 30, 2024 | -24.35 Mn |
| Mar 31, 2024 | -4.78 Mn |
| Mar 31, 2024 | -4.78 Mn |
| Dec 31, 2023 | 19.45 Mn |
| Dec 31, 2023 | 19.45 Mn |
| Sep 30, 2023 | 6.63 Mn |
| Sep 30, 2023 | 6.63 Mn |